2003年4月1日 · Diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state (HHS) appear as 2 extremes in the spectrum of diabetic decompensation. 1 They remain the most …

2018年6月25日 · Sodium–glucose cotransporter-2 (SGLT-2) inhibitors have been associated with euglycemic diabetic ketoacidosis. Precipitants to ketoacidosis include intercurrent illnesses, …

Clinical diagnosis is based on the finding of dehydration along with high capillary glucose levels with or without ketones in the urine or plasma. The diagnosis is confirmed by the blood pH, …

2003年4月1日 · Clinical diagnosis is based on the finding of dehydration along with high capillary glucose levels with or without ketones in the urine or plasma. The diagnosis is confirmed by …

2018年6月25日 · Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor CMAJ . 2018 Jun 25;190(25):E766-E768. doi: 10.1503/cmaj.171319.

2018年4月9日 · Background: Diabetic ketoacidosis is the leading cause of death among children with type 1 diabetes mellitus, and is an avoidable complication at first-time diagnosis of …

2021年6月1日 · Diabetic ketoacidosis (DKA) is a form of a hyperglycemic emergency mainly characterized by the triad of hyperglycemia, ketosis, and anion gap metabolic acidosis. DKA …

2021年9月7日 · Use of sodium-glucose co-transporter 2 (SGLT-2) inhibitors is currently classified as off-label in individuals less than 18 years of age in Canada. Use of SGLT-2 inhibitors may …

2022年10月1日 · Despite the numerous benefits of SGLT2 inhibitors on cardiac health, they can be associated with an increased risk of diabetic ketoacidosis, often with normal glucose levels …

2019年6月1日 · Diabetic ketoacidosis (DKA) is associated with significant morbidity and mortality. Using standardized protocols for DKA management improves outcomes and is recommended …